PANX Trademark

Trademark Overview

On Wednesday, July 19, 2023, a trademark application was filed for PANX with the United States Patent and Trademark Office. The USPTO has given the PANX trademark a serial number of 79384329. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 11, 2025. This trademark is owned by Leyden Laboratories B.V.. The PANX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment and prevention of viral diseases
panx

General Information

Serial Number79384329
Word MarkPANX
Filing DateWednesday, July 19, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2025

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment and prevention of viral diseases
Translation of Words in MarkThe wording "PANX" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLeyden Laboratories B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNL
Party NameLeyden Laboratories B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNL

Trademark Events

Event DateEvent Description
Monday, March 25, 2024ASSIGNED TO EXAMINER
Thursday, November 30, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 5, 2023APPLICATION FILING RECEIPT MAILED
Sunday, February 4, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, March 25, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 26, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 12, 2024REFUSAL PROCESSED BY MPU
Friday, April 12, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 8, 2024REFUSAL PROCESSED BY IB
Monday, October 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, October 16, 2024SUSPENSION LETTER WRITTEN
Wednesday, October 16, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, December 6, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, January 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 11, 2025ASSIGNED TO LIE
Thursday, January 16, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

panx viral diseases prevention treatment products pharmaceutical